Ocular Anti-Vegf Therapy for Diabetic Retinopathy: The Role of VEGF in the Pathogenesis of Diabetic Retinopathy

Diabetes Care - United States
doi 10.2337/dc13-2002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Ocular Anti-Vegf Therapy for Diabetic Retinopathy: Overview of Clinical Efficacy and Evolving Applications

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2014English

Diabetic Retinopathy and VEGF

Open Ophthalmology Journal
Ophthalmology
2013English

Laser or Anti‐VEGF for Proliferative Diabetic Retinopathy

Acta Ophthalmologica
MedicineOphthalmology
2018English

Optical Coherence Tomography Use for Estimation of the Efficacy of Anti VEGF Therapy in Diabetic Retinopathy and Diabetic Macular Edema.

The Professional Medical Journal
2019English

Unraveling the Role of Genetics in the Pathogenesis of Diabetic Retinopathy

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2019English

Association of VEGF Gene Polymorphisms With Diabetic Retinopathy: A Meta-Analysis

PLoS ONE
Multidisciplinary
2013English

VEGF as a Survival Factor in Ex Vivo Models of Early Diabetic Retinopathy

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2016English

Ocular Associations of Diabetes Other Than Diabetic Retinopathy

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2008English

Diabetic Retinopathy.

BMJ
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy